Aprepitant in the Prevention of Delayed Emesis Induced by Cyclophosphamide Plus Anthracyclines in Breast Cancer Patients
Status:
Terminated
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to compare efficacy and tolerability of aprepitant versus
dexamethasone in the prevention of delayed emesis induced by moderately emetogenic
chemotherapy (cyclophosphamide plus anthracyclines) in breast cancer patients.